Myriad Genetics Reports Unauthorized IT Network Access
Myriad Genetics experienced unauthorized access to its IT network on November 2, 2026, leading to a temporary suspension of testing and order management systems.
Stocks · News reference
8-K filing — MYRIAD GENETICS INC (MYGN)
Filed: 2026-11-05 AccNo: 0001628280-26-070659 Size: 166 KB Item 8.01: Other Events
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- edgar
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
TD Cowen Maintains Hold on Myriad Genetics, Raises Price Target to $6.75
Leerink Partners Maintains Market Perform on Myriad Genetics, Raises Price Target to $8
Myriad Genetics Detects Unauthorized Access In It Network On Nov. 2; Temporarily Suspended Testing Operations, Order Management Systems Due To Incident; Probing Potential Access To Patient Records
Myriad Genetics Reports Third Quarter 2026 Financial Results and Raises Full-Year Revenue Guidance
Myriad Genetics announced its financial results for the third quarter ended September 30, 2026, and increased the mid-point of its full-year 2026 revenue guidance.
Myriad Genetics Q3 Adj. EPS $(0.11) Beats $(0.20) Estimate, Sales $202.700M Beat $191.329M Estimate